Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill C Rubinstein

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Surgical Oncology|October 17, 2022
Deep learning image analysis quantifies tumor heterogeneity and identifies microsatellite instability in colon cancerJill C Rubinstein, Ali Foroughi Pour, Jie Zhou, et al.
Surgery|October 11, 2015
Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinomaJill C Rubinstein, Taylor C Brown, Gerald Goh, et al.
Journal of Pediatric Surgery|October 27, 2018
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancerJill C Rubinstein, Catherine Dinauer, Kayleigh Herrick-Reynolds, et al.
Surgery|October 12, 2015
DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinomaTaylor C Brown, C Christofer Juhlin, James M Healy, et al.
Journal of the Endocrine Society|December 22, 2017
Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 DeletionJill C Rubinstein, Sachin K Majumdar, William Laskin, et al.
Cancer Medicine|September 28, 2016
Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsyJill C Rubinstein, Gang Han, Laura Jackson, et al.
The Journal of Surgical Research|January 11, 2020
Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume PracticeJill C Rubinstein, Kayleigh Herrick-Reynolds, Catherine Dinauer, et al.
Surgery|January 12, 2017
Overexpression of cytochrome P450 2A6 in adrenocortical carcinomaTimothy D Murtha, Taylor C Brown, Jill C Rubinstein, et al.
Journal of Translational Medicine|July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.
Cancer Research|December 19, 2024
Spatiotemporal Profiling Defines Persistence and Resistance Dynamics during Targeted Treatment of MelanomaJill C Rubinstein, Sergii Domanskyi, Todd B Sheridan, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Surgical Oncology|October 17, 2022
Deep learning image analysis quantifies tumor heterogeneity and identifies microsatellite instability in colon cancerJill C Rubinstein, Ali Foroughi Pour, Jie Zhou, et al.
Surgery|October 11, 2015
Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinomaJill C Rubinstein, Taylor C Brown, Gerald Goh, et al.
Journal of Pediatric Surgery|October 27, 2018
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancerJill C Rubinstein, Catherine Dinauer, Kayleigh Herrick-Reynolds, et al.
Surgery|October 12, 2015
DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinomaTaylor C Brown, C Christofer Juhlin, James M Healy, et al.
Journal of the Endocrine Society|December 22, 2017
Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 DeletionJill C Rubinstein, Sachin K Majumdar, William Laskin, et al.
Cancer Medicine|September 28, 2016
Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsyJill C Rubinstein, Gang Han, Laura Jackson, et al.
The Journal of Surgical Research|January 11, 2020
Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume PracticeJill C Rubinstein, Kayleigh Herrick-Reynolds, Catherine Dinauer, et al.
Surgery|January 12, 2017
Overexpression of cytochrome P450 2A6 in adrenocortical carcinomaTimothy D Murtha, Taylor C Brown, Jill C Rubinstein, et al.
Journal of Translational Medicine|July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.
Cancer Research|December 19, 2024
Spatiotemporal Profiling Defines Persistence and Resistance Dynamics during Targeted Treatment of MelanomaJill C Rubinstein, Sergii Domanskyi, Todd B Sheridan, et al.
Pageof 3